BeOne Medicines (ONC) Non-Current Deffered Revenue (2017 - 2023)
BeOne Medicines (ONC) posted quarterly Non-Current Deffered Revenue of $300000.0 for Q4 2023, down 99.29% year-over-year from $42.0 million in Q4 2022, and little changed quarter-over-quarter from $300000.0 in Q3 2023.
BeOne Medicines (ONC) Non-Current Deffered Revenue (2017 - 2023) Analysis & Trends
BeOne Medicines (ONC) has reported Non-Current Deffered Revenue for 6 consecutive years, with $300000.0 the latest figure, recorded in Q4 2023.
- In Q4 2023, Non-Current Deffered Revenue fell 99.29% year-over-year to $300000.0; the TTM figure through Dec 2023 stood at $300000.0 (down 99.29% YoY), while the FY2023 annual figure was $300000.0, down 99.29% from the prior year.
- Non-Current Deffered Revenue was little changed at $300000.0 in Q4 2023 per ONC's latest filing, from $300000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $220.3 million in Q4 2021 and bottomed at $300000.0 in Q3 2023.
- Historically, Non-Current Deffered Revenue has averaged $81.6 million across 4 years, with a median of $52.3 million in 2021.
- Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue soared 186.77% — and 2023, when it sank 99.8%.
- BeOne Medicines' Non-Current Deffered Revenue stood at $8.2 million in 2019, then jumped by 2573.41% to $220.3 million in 2021, then slumped by 80.92% to $42.0 million in 2022, then sank by 99.29% to $300000.0 in 2023.
- Business Quant data shows ONC's Non-Current Deffered Revenue at $300000.0 in Q4 2023, $300000.0 in Q3 2023, and $24.3 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 220.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 24.28 Mn |
| Mar 31, 2023 | 37.35 Mn |
| Dec 31, 2022 | 42.03 Mn |
| Sep 30, 2022 | 149.90 Mn |
| Jun 30, 2022 | 167.57 Mn |
| Mar 31, 2022 | 204.37 Mn |
| Dec 31, 2021 | 220.29 Mn |
| Sep 30, 2021 | 52.27 Mn |
| Jun 30, 2021 | 75.27 Mn |
| Mar 31, 2021 | 78.59 Mn |
| Mar 31, 2019 | 8.24 Mn |
| Dec 31, 2018 | 9.84 Mn |
| Sep 30, 2018 | 14.66 Mn |
| Jun 30, 2018 | 18.30 Mn |
| Mar 31, 2018 | 21.29 Mn |
| Dec 31, 2017 | 24.81 Mn |
| Sep 30, 2017 | 29.48 Mn |